(ADCETRIS is US registered trademarks of Seattle Genetics, Inc.)

What is Adcetris:

ADECTRIS is a medicine that contains the active substance brentuximabvedotinwhich is available as powder that is made up into solution for infusion (drip into vein).

Which company market and owner of ADCETRIS brand:

ADCETRIS is product of Takeda Pharmaceutical Company Limited.ADCETRIS in US and Canada is marketed by Seattle Genetics.Adcetris is US registered trademarks of Seattle Genetics, Inc.

In how many countries Adcetris is approved for marketing:

Adcetrisis approved in more than 65 countries, including Brazil, Japan, the United States and countries in the European Union.Adcetris is not approved for marketing in India

What is Adcetris used for:

Adcetris is indicated to treat Hodgkin lymphoma in adult patients when the tumor cells are CD30-positive i.e. tumor cells have a protein called CD30 on their surface). Adcetris is used:

  • when the cancer has relapsed (come back) or has not responded to an autologous stem cell transplant;
  • When the cancer has relapsed or has not responded to at least two other previous therapies and when autologous stem cell transplant or chemotherapy (a combination of cancer medicines) cannot be used.
  • when patients have had an autologous stem cell transplant but are considered to be at increased risk of the cancer coming back or not responding;

Adcetris is also indicated to treat systemic anaplastic large cell lymphoma when the cancer has relapsed or has not responded to other previous treatments.

How can I getADCETRIS in India?

ADCETRIS is a prescription only drug, but not yet approved for marketing in India. However, as per the Drugs and Cosmetic Act 1940 and Rules 1945, provisions are in place for the personal import of unapproved drugs in India by a patient

Ikris Pharma Network (IPN) is a consulting pharmaceutical company which assists Patientsin preparing documentation for Name-Patient Medicine Import for their personal use. Ikris Pharma Network facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact IPN at + 91 120 2400370 or write to at – Our manager will get in touch with you to guide you further and will assist you in doing all the paper work for securing necessary permissions from Govt.of India before ADCETRIS is imported directly to you.

Ikris does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees

Can I getADCETRIS even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior tomarketing approval for personal use for patients who have exhausted all other treatment options available in their country IKRIS Pharma Network (IPN) can assist patients in accessingAdcetris even if it is unapproved against valid prescriptions in conformity with all local laws and regulations.

How is Adcetris used?

Adcetris should be administered under the guidance of specialist doctorhaving experience in managing cancer treatments The recommended dose is 1.8 mg/kg body weight. It is given by a 30-minute infusion into a vein every three weeks. Patients should always be monitored during and after the infusion for certain side effects and full blood counts should be checked before every dose of Adcetris. Treatment should continue for up to 1 year unless the disease progresses or severe side effects develop. If the patient develops certain seriousside effects then doctor may interrupt or stop treatment, or reduce the dose. See the summary of product characteristics on company official website for more information


ADCETRIS Brentuximab Vedotin for Injection

Prescribing Information

Contact Details

IKRIS Pharma Network Pvt. Ltd.
905 , I - Thum Business Park,
Plot No. A-40, Unit No. 5, Tower A,
Sector-62, Noida – 201301 (India)

Phone No.- +91-120–2400370.
M: + 91 8130290915

Query Form

Are there any side-effects/ adverse reactions/precautions associated with treatment with ADCETRIS?

It is recommended to seek your doctor’s medical advice about side effects

How do I contact Ikris Pharma Network?

You can use different channel to contact Ikris Pharma Network

Tele & Mobile: You can reach us on +91 81302 90915 or +91 120 2400370 on any working days.

Email: We can also address your enquiries if sent directly to We will respond within 24 hours after receiving your mail. Please mention detailed enquiry, your contact number withwith ISD code while sending your mail

Website: We have very active website www.ikrispharmanetwork.comwherein you can fill enquiry form displayed on the website. We will respond within 1 working days after receiving your query form.

Office: We will be happy to address your query directly if you can plan your visit to our office during working hours. Our office address is……. (please include google map here)

What is Named Patient Program?

New medicines which have been approved recently in USA or Europe but not yet approved in India or Rest of the world countries cannot be permitted to import or market commercially. However, they may be required for the treatment of some patients to save their lives who have exhausted all other available treatment options in their home country. Named – Patient Program is facilitate import of such medicines for personal use. There is a provision under the Indian Drugs and Cosmetics Rules, 1945, which permits needy patient to import these medicine for personal use in smaller quantities. Similar regulatory provision also exist in other countries as well.

We help such patient in preparing legal documents for import and connecting them with genuine suppliers to secure genuine products.

What information do youneed tohelp patient in assisting documentation for Adcetris import for personal use?

We will require the following documents to help in documentation for Named-Patient import
a. Doctor’s Prescription – We would require prescription from Registered Medical Practitioner stating Product name, dosage, duration of treatment and diagnosis
b. Patient’s Medical history – We would require all test reports and Medical reports of the patient for last 3 months.
c. Patient’s Identity card – We will require scan copy of Patient’s identity card and proof of residence to initiate documentation process. You can use copy of Passport, Driving License, Employee ID card or any Photo ID document as your Identity card.